Rapid Trade

A Biotech Firm's New Formula
Craig A. Rosen gets bored easily. During his last few years at Human Genome Sciences Inc., he oversaw the development of a $230 million manufacturing plant. Boring. He was promoted to chief operating officer. Boring. And president. Boring. The board of directors even talked to him about becoming…
Michael S. Rosenwald

This entry was posted on Monday, July 31st, 2006 at 12:03 pm and is filed under Financial News. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.